These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21231891)

  • 1. Regulatory and pathogenetic mechanisms of autoantibodies in SLE.
    Radic M; Herrmann M; van der Vlag J; Rekvig OP
    Autoimmunity; 2011 Aug; 44(5):349-56. PubMed ID: 21231891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenic role of antinuclear antibodies in lupus disease].
    Sany J
    Ann Med Interne (Paris); 1990; 141(3):222-6. PubMed ID: 2195947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptor 9-independent aggravation of glomerulonephritis in a novel model of SLE.
    Yu P; Wellmann U; Kunder S; Quintanilla-Martinez L; Jennen L; Dear N; Amann K; Bauer S; Winkler TH; Wagner H
    Int Immunol; 2006 Aug; 18(8):1211-9. PubMed ID: 16798839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus.
    Waisman A; Mozes E
    Eur J Immunol; 1993 Jul; 23(7):1566-73. PubMed ID: 8325334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus.
    Lartigue A; Colliou N; Calbo S; François A; Jacquot S; Arnoult C; Tron F; Gilbert D; Musette P
    J Immunol; 2009 Nov; 183(10):6207-16. PubMed ID: 19841185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes.
    Lee TP; Tang SJ; Wu MF; Song YC; Yu CL; Sun KH
    J Autoimmun; 2010 Dec; 35(4):358-67. PubMed ID: 20833510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic lupus erythematosus between clinical practice and the laboratory: state of the art and new findings on anti-DNA autoantibodies].
    Brusca I; Corrao S; Li Vigni P; Sucato R; La Chiusa SM
    Recenti Prog Med; 2002 Jun; 93(6):377-87. PubMed ID: 12085719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies within families of patients with systemic lupus erythematosus are not directed against the same nuclear antigens.
    van der Linden MW; Westendorp RG; Zidane M; Meheus L; Huizinga TW
    J Rheumatol; 2001 Feb; 28(2):284-7. PubMed ID: 11246662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do naturally occurring autoantibodies participate in the constitution of the pathological B-cell repertoire in systemic lupus erythematosus?
    Gilbert D; Brard F; Jovelin F; Tron F
    J Autoimmun; 1996 Apr; 9(2):247-57. PubMed ID: 8738970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific overview of systemic lupus erythematosus (SLE).
    Jasin HE
    Prog Clin Biol Res; 1982; 106():65-80. PubMed ID: 6757954
    [No Abstract]   [Full Text] [Related]  

  • 11. Elimination of autoreactive B cells in humanized SCID mouse model of SLE.
    Kerekov NS; Mihaylova NM; Grozdev I; Todorov TA; Nikolova M; Baleva M; Nikolova M; Prechl J; Erdei A; Tchorbanov AI
    Eur J Immunol; 2011 Nov; 41(11):3301-11. PubMed ID: 21830207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [B-cell anomalies in systemic lupus erythematosus].
    Tron F; Jacquot S; Gilbert D
    Ann Med Interne (Paris); 2002 Dec; 153(8):503-12. PubMed ID: 12610424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybridoma SLE autoantibodies: insights for the pathogenesis of autoimmune disease.
    Pisetsky DS
    Clin Immunol Rev; 1984; 3(2):169-234. PubMed ID: 6084573
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
    Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
    N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-establishing tolerance to DNA in humanized and murine models of SLE.
    Nikolova K; Mihaylova N; Voynova E; Kerekov N; Gesheva V; Prechl J; Nikolova M; Tchorbanov A
    Autoimmun Rev; 2010 May; 9(7):499-502. PubMed ID: 20149897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of TLR9 signaling in B cells impaired anti-dsDNA antibody production in mice induced by activated syngenic lymphocyte-derived DNA immunization.
    Chen M; Zhang W; Xu W; Zhang F; Xiong S
    Mol Immunol; 2011 Jul; 48(12-13):1532-9. PubMed ID: 21592581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus: mysterious disease holds its secrets tight.
    Marshall E
    Science; 2002 Apr; 296(5568):689-91. PubMed ID: 11976440
    [No Abstract]   [Full Text] [Related]  

  • 18. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered B-cell signaling in lupus.
    Liu K; Mohan C
    Autoimmun Rev; 2009 Jan; 8(3):214-8. PubMed ID: 18722559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.